Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
Authors
Keywords
-
Journal
International Journal of Chronic Obstructive Pulmonary Disease
Volume Volume 17, Issue -, Pages 1975-1986
Publisher
Informa UK Limited
Online
2022-08-30
DOI
10.2147/copd.s378486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perplexing mortality data from triple therapy trials in COPD
- (2021) Samy Suissa Lancet Respiratory Medicine
- Triple Therapy in COPD: Time for Adaptive Selection Trials
- (2021) Samy Suissa COPD-Journal of Chronic Obstructive Pulmonary Disease
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
- (2020) David A. Lipson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Effect of ICS Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study: A Randomized, Double-blind Multicenter Trial
- (2020) MeiLan K Han et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
- (2020) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
- (2020) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
- (2019) Achim Wolf et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice
- (2019) Samy Suissa et al. CHEST
- Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
- (2019) Hans‐Georg Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
- (2019) Rishi J Desai et al. BMJ-British Medical Journal
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Making Sense of Triple Inhaled Therapy for COPD
- (2018) Samy Suissa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
- (2018) Cristina Rebordosa et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Triple therapy trials in COPD: a precision medicine opportunity
- (2018) Samy Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
- (2018) Samy Suissa et al. Lancet Respiratory Medicine
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
- (2017) Claus F. Vogelmeier et al. EUROPEAN RESPIRATORY JOURNAL
- Run-in bias in randomised trials: the case of COPD medications
- (2017) Samy Suissa EUROPEAN RESPIRATORY JOURNAL
- Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
- (2017) Thomas R. Frieden NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
- (2016) Samy Suissa et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records
- (2016) Kieran J Rothnie et al. Clinical Epidemiology
- Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
- (2016) Kieran J. Rothnie et al. PLoS One
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
- (2014) J. K. Quint et al. BMJ Open
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
- (2012) Philip H. Quanjer et al. EUROPEAN RESPIRATORY JOURNAL
- Accuracy of pneumonia hospital admissions in a primary care electronic medical record database
- (2012) Sharon B. Meropol et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Validation and validity of diagnoses in the General Practice Research Database: a systematic review
- (2009) Emily Herrett et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search